226 related articles for article (PubMed ID: 17113088)
1. Role of gonadotropin-releasing hormone antagonists in poor responders.
Mahutte NG; Arici A
Fertil Steril; 2007 Feb; 87(2):241-9. PubMed ID: 17113088
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists.
Chung K; Krey L; Katz J; Noyes N
Fertil Steril; 2005 Aug; 84(2):313-8. PubMed ID: 16084870
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: a retrospective study.
Madani T; Ashrafi M; Yeganeh LM
Gynecol Endocrinol; 2012 Feb; 28(2):102-5. PubMed ID: 22263965
[TBL] [Abstract][Full Text] [Related]
4. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
5. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation.
Malmusi S; La Marca A; Giulini S; Xella S; Tagliasacchi D; Marsella T; Volpe A
Fertil Steril; 2005 Aug; 84(2):402-6. PubMed ID: 16084881
[TBL] [Abstract][Full Text] [Related]
7. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
8. GnRH antagonists in ovarian stimulation for IVF.
Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
[TBL] [Abstract][Full Text] [Related]
9. Poor responder protocols for in-vitro fertilization: options and results.
Loutradis D; Vomvolaki E; Drakakis P
Curr Opin Obstet Gynecol; 2008 Aug; 20(4):374-8. PubMed ID: 18660689
[TBL] [Abstract][Full Text] [Related]
10. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure.
Fisch JD; Keskintepe L; Sher G
Fertil Steril; 2008 Feb; 89(2):342-7. PubMed ID: 17562336
[TBL] [Abstract][Full Text] [Related]
12. [GnRH antagonists in natural cycles].
Frydman R
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S46-9. PubMed ID: 15643689
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.
De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C
Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769
[TBL] [Abstract][Full Text] [Related]
14. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?
Reichman DE; Chung P; Meyer L; Greenwood E; Davis O; Rosenwaks Z
Fertil Steril; 2013 Apr; 99(5):1277-82. PubMed ID: 23290740
[TBL] [Abstract][Full Text] [Related]
15. [Application of GnRH-antagonist to IVF-ET for patients with poor ovarian response].
Wang B; Sun HX; Hu YL; Chen H; Zhang NY
Zhonghua Nan Ke Xue; 2008 May; 14(5):423-6. PubMed ID: 18572861
[TBL] [Abstract][Full Text] [Related]
16. [Natural cycle in vitro fertilization cycle in poor responders].
Reyftmann L; Déchaud H; Loup V; Anahory T; Brunet-Joyeux C; Lacroix N; Hamamah S; Hédon B
Gynecol Obstet Fertil; 2007 Apr; 35(4):352-8. PubMed ID: 17336129
[TBL] [Abstract][Full Text] [Related]
17. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
[TBL] [Abstract][Full Text] [Related]
18. Novel follicular-phase gonadotropin-releasing hormone antagonist stimulation protocol for in vitro fertilization in the poor responder.
Frankfurter D; Dayal M; Dubey A; Peak D; Gindoff P
Fertil Steril; 2007 Nov; 88(5):1442-5. PubMed ID: 17481626
[TBL] [Abstract][Full Text] [Related]
19. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
20. [Biological assessment criteria during antagonist protocols].
Plachot M
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S32-5. PubMed ID: 15643685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
